Stocksigma LogoStocksigma Logo

Jubilant Ingrevia Q2'FY27 Results: PAT Surges 61% YoY Alongside ZettaOne Acquisition

Jubilant Ingrevia reported strong Q2'FY27 performance on 27th Oct'26, with revenue rising 24% YoY to an all-time high of ₹1,394 crore

Jubilant Ingrevia Q2'FY27 Results: PAT Surges 61% YoY Alongside ZettaOne Acquisition

Jubilant Ingrevia Ltd · Press Release · 27 Oct 2026, 8:19 pm

Jubilant Ingrevia Q2'FY27 Results: PAT Surges 61% YoY Alongside ZettaOne Acquisition Jubilant Ingrevia reported strong Q2'FY27 performance on 27th Oct'26, with revenue rising 24% YoY to an all-time high of ₹1,394 crore. EBITDA surged 51% YoY to ₹221 crore, expanding margins to 16%, while PAT rose 61% YoY to ₹111 crore. Growth was led by Chemical Intermediates (EBITDA up 226% YoY) and Nutrition & Health Solutions (EBITDA up 87% YoY). The company also announced a 40% strategic stake acquisition in ZettaOne Technologies for ₹189.2 crore to enter the electronics and semiconductor EDMS space.

Original exchange filing (PDF)

More announcements from Jubilant Ingrevia Ltd

All Jubilant Ingrevia Ltd announcements